Labeler
Antares Pharma, Inc. NDC Codes
Antares Pharma, Inc. lists 11 finished drug products in the FDA NDC Directory under NDC labeler codes 18657, 54436.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Otrexup, Xyosted, HYLENEX Recombinant
- Active ingredients
- Methotrexate, Testosterone enanthate, Hyaluronidase (Human recombinant)
- NDC labeler codes
- 18657, 54436
- Strengths
- Testosterone enanthate 100 mg/.5mL; Testosterone enanthate 50 mg/.5mL; Testosterone enanthate 75 mg/.5mL; Methotrexate 10 mg/.4mL; Methotrexate 12.5 mg/.4mL; Methotrexate 15 mg/.4mL; Methotrexate 17.5 mg/.4mL; Methotrexate 20 mg/.4mL; Methotrexate 22.5 mg/.4mL; Methotrexate 25 mg/.4mL; Hyaluronidase (Human recombinant) 150 [USP'U]/mL
- Dosage forms
- Injection, Solution, Injection
- Routes
- Subcutaneous
- Drug classes (FDA established)
- Folate Analog Metabolic Inhibitor, Androgen, Endoglycosidase
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 30
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Xyostedtestosterone enanthate | Testosterone enanthate 100 mg/.5mL | InjectionSubcutaneous | 54436-200 | 54436-0200-0154436-0200-0454436-0200-05 | — |
| Xyostedtestosterone enanthate | Testosterone enanthate 50 mg/.5mL | InjectionSubcutaneous | 54436-250 | 54436-0250-0154436-0250-04 | — |
| Xyostedtestosterone enanthate | Testosterone enanthate 75 mg/.5mL | InjectionSubcutaneous | 54436-275 | 54436-0275-0154436-0275-0454436-0275-05 | — |
| Otrexupmethotrexate | Methotrexate 10 mg/.4mL | Injection, SolutionSubcutaneous | 54436-010 | 54436-0010-0154436-0010-0354436-0010-04 | — |
| Otrexupmethotrexate | Methotrexate 12.5 mg/.4mL | Injection, SolutionSubcutaneous | 54436-012 | 54436-0012-0154436-0012-0354436-0012-04 | — |
| Otrexupmethotrexate | Methotrexate 15 mg/.4mL | Injection, SolutionSubcutaneous | 54436-015 | 54436-0015-0154436-0015-0354436-0015-04 | — |
| Otrexupmethotrexate | Methotrexate 17.5 mg/.4mL | Injection, SolutionSubcutaneous | 54436-017 | 54436-0017-0154436-0017-0354436-0017-04 | — |
| Otrexupmethotrexate | Methotrexate 20 mg/.4mL | Injection, SolutionSubcutaneous | 54436-020 | 54436-0020-0154436-0020-0354436-0020-04 | — |
| Otrexupmethotrexate | Methotrexate 22.5 mg/.4mL | Injection, SolutionSubcutaneous | 54436-022 | 54436-0022-0154436-0022-0354436-0022-04 | — |
| Otrexupmethotrexate | Methotrexate 25 mg/.4mL | Injection, SolutionSubcutaneous | 54436-025 | 54436-0025-0154436-0025-0354436-0025-04 | — |
| HYLENEX Recombinanthyaluronidase | Hyaluronidase (Human recombinant) 150 [USP'U]/mL | Injection, SolutionSubcutaneous | 18657-117 | 18657-0117-04 | — |
Antares Pharma, Inc.: common questions
- What is Antares Pharma, Inc.'s NDC labeler code?
- 18657, 54436. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Antares Pharma, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.